Important Innovations

Alphabet's Isomorphic Labs Using AI To Discover New Pharma Drugs                                  Source:  Google & Stock AI Images AI Could Accelerate Development & Cut Costs of New Drugs Google's innovation incubator Alphabet is putting artificial intelligence (AI) to work for the discovery of new pharmaceutical drugs.  Alphabet has launched a new company Isomorphic Labs in the UK to deploy advancements made by Alphabet's DeepMind AI to predict the shape of proteins with "incredible accuracy".  DeepMind's AI uses a model called AlphaFold2 to predict breakthrough proteins and their shape in the human body.  This capability is said by experts to be critical in the development of breakthrough drug therapies.   What Is the Significance of Alphabet's Move? It has great significance on a number of levels.  This fascinating development moves Google and Big Tech deeper into the healthcare industry.  The big hope and expectation are that AI will cut the t

Alphabet's Isomorphic Labs Using AI To Discover New Pharma Drugs                                  Source:  Google & Stock AI Images AI Could Accelerate Development & Cut Costs of New Drugs Google's innovation incubator Alphabet is putting artificial intelligence (AI) to work for the discovery of new pharmaceutical drugs.  Alphabet has launched a new company Isomorphic Labs in the UK to deploy advancements made by Alphabet's DeepMind AI to predict the shape of proteins with "incredible accuracy".  DeepMind's AI uses a model called AlphaFold2 to predict breakthrough proteins and their shape in the human body.  This capability is said by experts to be critical in the development of breakthrough drug therapies.   What Is the Significance of Alphabet's Move? It has great significance on a number of levels.  This fascinating development moves Google and Big Tech deeper into the healthcare industry.  The big hope and expectation are that AI will cut the t

AI System Designs New Drug Medications from Scratch Accelerates Drug Development Process A new artificial intelligence system called ReLeASE has been developed by scientists at the University of North Carolina Chapel Hill.  It greatly lessens the time to design new drug molecules from scratch.  It could potentially release the floodgates for the development of new medicines.  A blockbuster drug typically takes $3 billion and 10 years to create. Big Breakthrough What's different about ReLeASE, according to the scientists, is its unique ability to create new molecules.  The algorithm can design new, "immediately patentable" medicine with optimal safety profiles and specific biological activity.  This should significantly shorten the time to bring new drug candidates into clinical trials. Two Neural Networks Working Together ReLeASE stands for Reinforcement Learning for Structural Evolution.  It's comprised of two neural networks.  The researchers think of